Pancreatic Cancer Research

ResearcherNanchang UniversityActive in the last 2 years

Jinli He

Provisional: name at one institution (moderate confidence)As of 10 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in OpenAlex.

Their work

Papers
2 (first author 2, last author 0)
Trials
0
Grants
0
Collaborators
3
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. First author DOI 10.1002/cam4.70446↗
  2. RGC-32 facilitates pancreatic cancer via activating Wnt/β-catenin signaling. First author DOI 10.14715/cmb/2023.69.14.26↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Ying Ding · 1 shared paper, 2024
  2. Liang Zhu · 1 shared paper, 2024
  3. Liang Zhu · 1 shared paper, 2023

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.